
โน4,399 Original price was: โน4,399.โน1,600Current price is: โน1,600.
Order Online
Need a prescription?
Consult our doctor and get one online.
Uses & Benefits
Uses & Benefits
Key Benefits
Alafevir DE Tablet combines three powerful antiretroviral drugs that work by blocking different steps of the HIV replication cycle. Dolutegravir inhibits viral integration into human DNA, while Emtricitabine and Tenofovir Alafenamide prevent the virus from multiplying, leading to reduced viral load and improved immune function.
Caution is advised when consuming alcohol with Alafevir DE Tablet. Please consult your doctor for guidance.
Alafevir DE Tablet is unsafe to use during pregnancy due to potential harm to the developing baby. It may only be prescribed in life-threatening situations where benefits outweigh the risks. Please consult your doctor.
There is insufficient information on the use of Alafevir DE Tablet while breastfeeding. Please consult your doctor before use.
It is uncertain whether Alafevir DE Tablet affects your ability to drive. Avoid driving if you experience drowsiness, dizziness, or reduced alertness.
Limited data is available on the safety of Alafevir DE Tablet in patients with kidney disease. Dose adjustments may be necessary. Please consult your doctor.
Alafevir DE Tablet should be used with caution in patients with liver disease. Dose adjustments may be required based on the severity of the condition. Please consult your doctor.
โน1,633 Original price was: โน1,633.โน1,359Current price is: โน1,359.
โน1,829 Original price was: โน1,829.โน1,100Current price is: โน1,100.
โน4,389 Original price was: โน4,389.โน1,600Current price is: โน1,600.
โน3,242 Original price was: โน3,242.โน900Current price is: โน900.
โน2,167 Original price was: โน2,167.โน1,700Current price is: โน1,700.
Before You Go
The HIV Test Kit Is Still FREE
A private HIV self-test, delivered in plain packaging. Result in 20 minutes, at home. No cost, no clinic visit, and a TAAL+ doctor on call whichever way it goes.
Offer valid only in India till 30 September 2026. T&Cs apply.